Trials / Completed
CompletedNCT04170439
Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCO
The Added Value of n Acetyle Cysteine and Chromium to Clomiphene Citrate in PCO
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
PCO is one of the factors associated with delayed conception
Detailed description
In an attempt to induce ovulation Clomiphene citrate can be given in conjunction with N acetyle cysteine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clomiphene plus metformin plus N acetyle cysteine in arm number 1 | oral adminstration of clomiphene citrate plus metformin plus N acetyl cysteine or chromium |
| DRUG | Clomiphene citrate plus metformin with chromium | oral adminstration of clomiphene citrate plus metformin and chromium |
| DRUG | clomiphene citrate plus metformin | oral adminstration of clomiphene citrate plus metformin |
Timeline
- Start date
- 2019-11-20
- Primary completion
- 2020-05-02
- Completion
- 2020-05-15
- First posted
- 2019-11-20
- Last updated
- 2021-04-28
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04170439. Inclusion in this directory is not an endorsement.